Form 8-K ImmunityBio, Inc. For: Mar 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Tesla acquires AI hardware company for up to $2 billion in stock
ImmunityBio (IBRX) Provides Update on BLA for N-803
March 20, 2023 8:49 AM EDTImmunityBio (NASDAQ: IBRX) continues to explore partnering with a large biopharmaceutical co for commercialization of N-803 for administration intravesically.
continues to engage in ongoing discussions and dialogue with FDA, including proposed label for product candidate under review in... More